Tumour growth rate (TGR) when using lanreotide Autogel (R) (LAN) before, during and after peptide receptor radionuclide therapy (PRRT) in advanced neuroendocrine tumours (NETs)
Authors
Prasad, VSrirajaskanthan, R
Grana, CM
Baldari, S
Shah, T
Lamarca, Angela
Courbon, F
Scheidhauer, K
Baudin, E
Truong-Thanh, XM
Houchard, A
Bodei, L
Affiliation
Department of Nuclear Medicine, Universitaetsfrauenklinik Ulm, Ulm, GermanyIssue Date
2018
Metadata
Show full item recordCitation
Prasad V, Srirajaskanthan R, Grana CM, Baldari S, Shah T, Lamarca A, et al. 1331P Tumour growth rate (TGR) when using lanreotide Autogel� (LAN) before, during and after peptide receptor radionuclide therapy (PRRT) in advanced neuroendocrine tumours (NETs). Annals of Oncology. 2018;29(suppl_8).Journal
Annals of OncologyDOI
10.1093/annonc/mdy293.024PubMed ID
No PMIDAdditional Links
https://dx.doi.org/10.1093/annonc/mdy293.024Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdy293.024